Medtronic To Seek HDE For Activa To Treat Obsessive-Compulsive Disorder
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's pursuit of Activa deep-brain stimulation to treat chronic obsessive-compulsive disorder will serve as a springboard to the lucrative depression market, the company predicts